Vaccine countdown update: 10 Nov - positive results from some, cash flow concerns with others
A metal processor covered here would appear to justify a much higher rating, while cash flow concerns continue to cast a shadow over a once popular litigation funder. Read on here for more on these and other stories.
The news that Pfizer and Germany’s BioNTech have made progress with a Covid-19 vaccine saw stock markets soar, although not all stocks rose, with some beneficiaries of the pandemic, notably small UK biotech stocks, falling sharply, as many clearly think their glory days will soon be coming to an end.
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on James Cropper
Another £1 billion company for AIM | Fuel cell potential and more
AIM welcomed two newcomers, with the valuation of one rising to over £1 billion. Elsewhere, there…
Plenty of growth to enjoy here
Results and updates from smaller AIM companies covered here offer plenty of encouragement, with potential AIM…
More on Jubilee Metals Group
Strap yourself in for the commodity supercycle
Are we on the verge of a new commodity supercycle, including gold and silver copper and…
Vaccine countdown update: 10 Nov - positive results from some, cash flow concerns with others
A metal processor covered here would appear to justify a much higher rating, while cash flow…
More on Manolete Partners PLC
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Our coverage here includes several modestly valued companies whose shares should recover strongly when the world…
Vaccine countdown update: 10 Nov - positive results from some, cash flow concerns with others
A metal processor covered here would appear to justify a much higher rating, while cash flow…
More on Zoo Digital
Vaccine countdown update: 10 Nov - positive results from some, cash flow concerns with others
A metal processor covered here would appear to justify a much higher rating, while cash flow…
Coronavirus impact: 14 July - plenty of updates and a bizarre response from Manolete
Plenty of results and updates today, including a robust response from Manolete Partners, an insolvency litigation financing firm,…
